Propranolol enhanced the anti-tumor effect of sunitinib by inhibiting proliferation and inducing G0/G1/S phase arrest in malignant melanoma.

about

Propranolol enhanced the anti-tumor effect of sunitinib by inhibiting proliferation and inducing G0/G1/S phase arrest in malignant melanoma.

Item

http://www.wikidata.org/entity/Q49386480

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Propranolol enhanced the anti- ...... arrest in malignant melanoma.

@en

Propranolol enhanced the anti- ...... arrest in malignant melanoma.

@nl

type

Item

label

Propranolol enhanced the anti- ...... arrest in malignant melanoma.

@en

Propranolol enhanced the anti- ...... arrest in malignant melanoma.

@nl

prefLabel

Propranolol enhanced the anti- ...... arrest in malignant melanoma.

@en

Propranolol enhanced the anti- ...... arrest in malignant melanoma.

@nl

P1476

Propranolol enhanced the anti- ...... e arrest in malignant melanoma

@en

P2093

Chengfang Zhou

http://www.w3.org/2001/XMLSchema#string

Cong Peng

http://www.w3.org/2001/XMLSchema#string

Fangfang Li

http://www.w3.org/2001/XMLSchema#string

Hong Liu

http://www.w3.org/2001/XMLSchema#string

Jianglin Zhang

http://www.w3.org/2001/XMLSchema#string

Juan Su

http://www.w3.org/2001/XMLSchema#string

Juan Tao

http://www.w3.org/2001/XMLSchema#string

Junchen Chen

http://www.w3.org/2001/XMLSchema#string

Min Qi

http://www.w3.org/2001/XMLSchema#string

Mingliang Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Sunitinib therapy for melanoma patients with KIT mutations.

A randomized, controlled trial of oral propranolol in infantile hemangioma.

Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma.

Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival

Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment.

β2-adrenoceptor blockage induces G1/S phase arrest and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway

Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.

β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study

Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model.

Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma.

P304

802-811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22696

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Minxue Shen

P577

2017-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29416656

http://www.w3.org/2001/XMLSchema#string

P932

5787512

http://www.w3.org/2001/XMLSchema#string